Positive Short-Term Effect of Low-Dose Rosuvastatin in a Patient with SYNGAP1-Associated Epilepsy

Neuropediatrics. 2019 Aug;50(4):266-267. doi: 10.1055/s-0039-1681066. Epub 2019 Mar 15.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / therapeutic use*
  • Epilepsy / drug therapy*
  • Epilepsy / genetics
  • Female
  • Humans
  • Rosuvastatin Calcium / therapeutic use*
  • Treatment Outcome
  • Young Adult
  • ras GTPase-Activating Proteins / genetics*

Substances

  • Anticonvulsants
  • SYNGAP1 protein, human
  • ras GTPase-Activating Proteins
  • Rosuvastatin Calcium